Your search returned 2 results.

Results
	1.	Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis. [electronic resource] by Miler, Emma Stapleton, Philip P Mapplebeck, Sarah Mackerness, Craig Gayford, Dawn Aung, Tin Wilson, Lisa Schofield, Paul Dasgupta, Bhaskar Producer: 20200406 In: International journal of rheumatic diseases vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis. [electronic resource] by Raine, Charles Stapleton, Philip P Merinopoulos, Dimos Maw, Win Win Achilleos, Katerina Gayford, Dawn Mapplebeck, Sarah Mackerness, Craig Schofield, Paul Dasgupta, Bhaskar Producer: 20180827 In: International journal of rheumatic diseases vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search